Travis E. Grotz, M.D.

The purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with gastric adenocarcinoma with limited low volume peritoneal metastasis and/or positive peritoneal cytology undergoing robotic cytoreduction and hyperthermic intraperitoneal chemotherapy.

The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment.

The purpose of this study is to compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

The purpose of this study is to:

1. Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester.
2. Design and implement quality improvement projects utilizing this database
3. Design and implement outcomes research using this prospective database
4. Design and implement quality of life studies using this prospective database

The purpose of this study is to establish a clinical useful gene expression panel for detecting and predicting peritoneal relapse and survival to address the unmet clinical need for a simple and accurate staging of the peritoneum in gastric cancer.